Immune monitoring has long depended on venous blood draws—accurate but limited by infrastructure, cost, and patient burden. Now, saliva is emerging as a scientifically validated alternative, carrying both systemic (IgG) and mucosal (IgA) immune markers. Paired with the unmatched sensitivity of Quanterix’s Simoa® platform, saliva becomes more than a convenient matrix, it becomes a powerful tool for precision research.
In this application note, you’ll discover:
Validated in peer-reviewed studies, saliva-based Simoa® assays open new possibilities for scalable, noninvasive immune monitoring, without sacrificing rigor, reproducibility, or analytical depth.
Fill out the form to download your copy of the application note and explore how saliva and Simoa® are redefining the future of immune monitoring.
![]() |
APP NOTE Expanding Access to Ultra-Sensitive Biomarker Testing: Urine as a Non-Invasive Matrix for Simoa Assays |
![]() |
PUBLICATION BRIEF Beyond Blood: Expanding Simoa Applications in Urine, Saliva, Sweat, & Tears |
![]() |
WEBINAR Decoding Alzheimer’s: The History, Biomarkers, and Clinical Advances |